InvestorsHub Logo
Followers 21
Posts 1596
Boards Moderated 1
Alias Born 09/16/2008

Re: danstheman9 post# 410049

Friday, 05/20/2011 3:03:54 PM

Friday, May 20, 2011 3:03:54 PM

Post# of 704570
FDA approval for Augment is expected sometime in the next 6 months. Augment received a favorable FDA Panel vote last week. BioMimetic CEO and BioMimetic VP / Regulatory & Clinical Affairs bought shares in the open market the past few days, so they must also feel Augment will get FDA approval. JPM has price target of $17 for BMTI. I think with FDA approval, $35+ is possible, imo.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.